Brief: Avita Medical Receives FDA Approval Of Recell For Treatment Of Full- Thickness Skin Defects
08/06/2023 02:31
June 8 (Reuters) - AVITA Medical Inc RCEL.O :
* FDA APPROVAL OF RECELL FOR TREATMENT OF FULL- THICKNESS
SKIN
DEFECTS
Source text for Eikon: ID:nASX3k3vQ5
Further company coverage: RCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing